(Q113886060)
Statements
An Open-Label, Paralleled Study of the Pharmacokinetics of HMS5552 Following a Single Oral Dose in Mild and Moderate Hepatic Impaired Subjects and Matched Healthy Volunteers (English)
0 references
18 February 2019
0 references
September 2020
0 references
24
0 references
18 year
0 references
65 year
0 references